查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577518

女性科技全球市场

FemTech
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球女性科技市场预计将达到 1,070 亿美元

预计 2023 年全球女性科技市场规模为 366 亿美元，预计到 2030 年将达到 1,070 亿美元，2023-2030 年分析期间复合年增长率为 16.6%。 Femtech 设备是本报告分析的细分市场之一，预计复合年增长率为 16.8%，到分析期结束时将达到 388 亿美元。分析期间，女性科技软体产业的复合年增长率预计为 18.1%。

美国市场预计将成长96亿美元，中国复合年增长率为15.5%

到 2023 年，美国女性科技市场预计将达到 96 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达163亿美元，2023-2030年分析期间复合年增长率为15.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 15.2% 和 14.2%。在欧洲，德国的复合年增长率预计约为 12.1%。

全球女性科技市场—主要趋势与驱动因素总结

为什么女性科技成为全球医疗保健领域的主要力量？

Femtech 是女性科技的缩写，专注于满足女性健康和保健需求的技术和创新，是全球医疗保健领域快速发展的技术。该市场包括数位健康解决方案、穿戴式装置、行动应用程式、诊断工具，特别是针对生殖健康、怀孕护理、更年期、月经健康、不孕症、性健康和一般健康等问题的产品。随着人们对女性独特医疗保健需求的认识不断增强，女性科技正成为提供传统上在医疗保健创新中代表性不足的解决方案的重要参与者。

女性科技兴起的主要原因之一是，在行动科技、穿戴式装置和数位健康平台等进步的支持下，女性对其健康的影响力不断增强。女性越来越多地使用科技来追踪她们的月经週期、监测她们的生育能力、管理她们的怀孕、获得远端医疗服务，并对她们的医疗决策有更大的自主权。此外，传统医疗保健提供者长期以来一直未能解决许多女性健康问题，例如更年期和月经失调，这使得女性科技解决方案目前正在解决这一空白。对满足女性独特生物需求的个人化医疗解决方案的需求激增，正在推动女性科技的快速成长。

此外，社会向性别平等的转变和对妇女健康问题认识的提高正在提高该市场的知名度。公共卫生宣传活动、领导职位中女性人数的增加以及女性企业家的崛起都有助于推动针对女性的创新医疗保健解决方案的发展。随着政府、医疗保健提供者和投资者认识到更有效地解决女性健康问题所带来的经济和社会效益，女性科技在全球范围内获得了巨大的关注，并为更全面的医疗保健铺平了道路。

科技进步如何增强女性科技解决方案？

科技进步正在彻底改变女性科技，提高女性健康解决方案的功能性、可及性和个人化。女性科技最重要的创新之一是行动医疗(行动医疗 ) 应用程式的兴起，这些应用程式允许女性追踪和管理其生殖生活的各个方面。 Clue、Flo 和 Natural Cycles 等应用程式可让使用者监测月经週期、预测排卵、追踪症状，并深入了解自己的生育能力和整体健康状况。这些应用程式使用人工智慧 (AI) 和机器学习演算法来分析资料并提供个人化建议，帮助女性了解其独特的健康模式。此外，这些数位平台为女性提供量身定制的健康见解，使她们能够就避孕、生育治疗和一般健康做出明智的决定。

穿戴式科技是女性科技进步的另一个主要领域。智慧手环和贴片等穿戴式装置配备了感测器，可以监测生命征象、荷尔蒙水平和其他与女性健康相关的生理指标。例如，Ava 等穿戴式装置使用生理资料来追踪受孕窗口，并为女性提供一种非侵入性的方式来管理其生育计画。由于生物感测技术的进步，这些设备变得越来越复杂，可以即时监测直接影响生殖和整体健康的因素，例如荷尔蒙波动、压力水平甚至睡眠模式。穿戴式装置和智慧型手机应用程式整合还透过资料同步来改善用户体验，以进行全面的健康追踪和分析。

远端医疗和远距医疗保健服务的进步正在进一步扩大女性科技市场。虚拟医疗平台使女性更容易获得医疗咨询，特别是在孕产妇护理、性健康和更年期管理等领域。专注于女性健康的远端医疗服务为患者提供了一种便捷的方式来获得专家建议、处方笺和治疗方案，而无需亲自去医生办公室。这种可近性对于生活在农村和服务不足地区的妇女尤其有价值，因为这些地区获得专门医疗保健的机会可能有限。随着远端医疗和人工智慧诊断的兴起，女性科技正在透过使其更加方便、个人化和随时可用来提高女性护理品质。

不断变化的消费者偏好和社会趋势如何塑造女性科技市场？

不断变化的消费者偏好和社会趋势在塑造全球女性科技市场方面发挥关键作用。尤其是，越来越多的女性正在寻求个人化、便利且容易取得的医疗保健解决方案。这一趋势的关键驱动因素之一是人们对自我护理和预防医学日益增长的兴趣。女性在管理自己的健康方面变得更加积极主动，并正在寻找工具来追踪、了解和改善她们的身心健康。 Femtech 解决方案，例如生育追踪应用程式、经期管理工具和更年期支援设备，提供量身定制的医疗保健选项，帮助女性管理自己的独特需求，而不必仅依赖传统的医疗保健提供者，这符合这一趋势。

对特定性别医疗保健挑战的认识不断提高也影响着消费者的行为。几十年来，月经失调、子宫内膜异位症和更年期等女性健康问题要么诊断不足，要么调查不足。医疗保健服务方面的这种差距导致了对专门针对女性需求的专业解决方案的需求。从荷尔蒙监测穿戴装置到骨盆底肌肉训练器，消费者需要能够为这些问题提供真正解决方案的产品和服务，从而开闢女性科技创新的新途径。这些趋势也体现在对帮助人们管理性健康的产品的需求上，例如智慧凯格尔训练器和提供性健康教育的应用程序，所有这些都有助于更全面的女性健康管理。

包括医疗保健在内的所有领域的性别平等和代表性社会运动也是塑造女性科技市场的重要趋势。女性企业家、创新者和医疗保健专业人员在开发解决妇女健康问题的产品和服务方面处于主导，并确保这些需求在更广泛的医疗保健系统中得到优先考虑。随着投资者认识到该市场开拓的潜力和盈利，对女性科技新兴企业的创业投资投资也在增加。此外，围绕生殖权利、医疗保健中的性别平等以及消除女性健康问题的争论使女性科技公司更容易提高自己的形象并更有效地行销其产品。

此外，数位平台和社交媒体的兴起使女性科技公司能够直接与消费者互动，从而创建社区主导的医疗保健方法。许多女性科技品牌正在利用社群媒体来教育和增强女性健康，解决月经、不孕和更年期等传统禁忌话题。公司和消费者之间的这种公开对话正在创造一个更具包容性的环境，让女性更轻鬆地讨论自己的健康需求并寻求适合她们的解决方案。消费者偏好的这些变化，加上性别平等和透明度的社会趋势，正在推动女性科技市场的成长，并为女性创造更个人化的医疗保健体验。

全球女性科技市场成长的驱动力是什么？

全球女性科技市场的成长受到几个关键因素的推动，包括增加对女性健康解决方案的投资、技术创新以及消费者对个人化医疗保健的需求不断增长。这一成长的关键驱动力之一是创业投资和医疗保健投资者的关注和资金筹措的增加，他们认识到女性科技的巨大市场潜力。从历史上看，女性健康在医疗保健创新中一直资金不足且代表性不足，但近年来，随着行业认识到对专业产品和服务的需求，投资激增。专注于生殖健康、孕产妇护理和更年期管理的女性科技新兴企业正在获得巨大的关注，多家公司筹集了大量资金来开发尖端产品并扩大其市场份额。

成长的另一个主要驱动力是人们对妇女健康问题的认识不断增强以及向预防保健的转变。穿戴式科技和行动医疗应用程式的兴起使女性能够透过追踪月经週期、监测生育能力和即时管理慢性疾病来掌控自己的健康。这些技术使妇女能够做出明智的医疗保健决定，并在需要时寻求早期干预，减轻传统医疗保健系统的负担并改善长期健康驱动结果。对预防性医疗保健解决方案的需求，特别是在不孕症管理和怀孕护理等领域，预计将推动女性科技市场的进一步扩张。

全球对改善女性健康日益增长的兴趣也在推动女性科技的采用方面发挥关键作用。世界各地的政府和医疗保健组织正在发起旨在解决妇女健康挑战的倡议，从改善生殖保健服务到提供更好的孕产妇护理服务。在获得医疗保健机会有限的发展中地区尤其如此，而女性科技解决方案提供了一种有效的方法来弥补女性医疗保健方面的差距。提供远端医疗、教育资源和健康追踪工具的行动医疗平台在这些地区特别有价值，可以推动市场成长并改善健康公平。

最后，健康和个人化医疗保健的社会趋势对女性科技市场的成长做出了重大贡献。随着消费者越来越重视自我护理和个人化健康解决方案，女性科技产品正成为各年龄层女性健康习惯的重要组成部分。从生育追踪设备和应用程式到荷尔蒙监测穿戴式装置和骨盆健康解决方案，femtech 提供的产品可提供即时见解和个人化护理，帮助女性掌控自己的健康。对个人化、技术主导的医疗保健的需求不断增长，正在推动女性科技的创新和投资，使其在全球市场上持续成长。

由于投资增加、技术进步、消费者对预防性和个人化护理的需求不断增长以及全球对改善女性健康的兴趣日益浓厚，全球女性科技市场正在迅速扩张。随着医疗保健产业继续优先考虑女性健康并解决长期存在的照护差距，女性科技在改变世界各地女性医疗保健的未来方面可以发挥重要作用。

受访企业范例（共39家）

  • Aavia
  • Allara Health
  • Athena Feminine Technologies, Inc.
  • BioWink GmbH（Clue）
  • Bloomlife
  • Canopie Inc.
  • Coroflo Limited
  • Flo Health
  • Glow Inc.
  • LunaJoy

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP24365

Global FemTech Market to Reach US$107.0 Billion by 2030

The global market for FemTech estimated at US$36.6 Billion in the year 2023, is expected to reach US$107.0 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2023-2030. FemTech Devices, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$38.8 Billion by the end of the analysis period. Growth in the FemTech Software segment is estimated at 18.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.6 Billion While China is Forecast to Grow at 15.5% CAGR

The FemTech market in the U.S. is estimated at US$9.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$16.3 Billion by the year 2030 trailing a CAGR of 15.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.2% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Global FemTech Market – Key Trends & Drivers Summarized

Why Is FemTech Gaining Major Traction in the Global Healthcare Landscape?

FemTech, short for female technology, has emerged as a rapidly growing segment in the global healthcare landscape, focusing on technology and innovations that cater to women’s health and wellness needs. This market includes digital health solutions, wearables, mobile apps, diagnostic tools, and products that specifically address issues such as reproductive health, pregnancy care, menopause, menstrual health, fertility, sexual health, and general wellness. With increasing awareness of women’s unique healthcare needs, FemTech is becoming a critical player in providing solutions that have been historically underrepresented in healthcare innovation.

One of the key reasons for the rise of FemTech is the increasing empowerment of women to take control of their health, supported by advancements in mobile technology, wearable devices, and access to digital health platforms. Women are increasingly turning to technology to track menstrual cycles, monitor fertility, manage pregnancy, and access telemedicine services, giving them greater autonomy over their healthcare decisions. Additionally, many women’s health issues, such as menopause or menstrual disorders, have long been underserved by traditional healthcare providers, leaving a gap that FemTech solutions are now addressing. This surge in demand for personalized healthcare solutions that cater to women’s unique biological needs is driving the rapid growth of FemTech.

Furthermore, societal shifts toward gender equality and increased focus on women’s health issues have brought more attention to this market. Public health campaigns, greater representation of women in leadership positions, and the rise of women entrepreneurs have all contributed to the push for more innovative healthcare solutions for women. As governments, healthcare providers, and investors recognize the economic and social benefits of addressing women’s health more effectively, FemTech is gaining significant traction worldwide, paving the way for more inclusive healthcare technologies.

How Are Technological Advancements Enhancing FemTech Solutions?

Technological advancements are revolutionizing FemTech by improving the functionality, accessibility, and personalization of women’s health solutions. One of the most significant innovations in FemTech has been the rise of mobile health (mHealth) apps that allow women to track and manage various aspects of their reproductive health. Apps like Clue, Flo, and Natural Cycles enable users to monitor their menstrual cycles, predict ovulation, and track symptoms, offering insights into fertility and overall health. These apps use artificial intelligence (AI) and machine learning algorithms to analyze data and provide personalized recommendations, making it easier for women to understand their unique health patterns. Additionally, these digital platforms empower women to make informed decisions about contraception, fertility treatments, and general health by providing them with tailored health insights.

Wearable technology is another major area of advancement within FemTech. Wearable devices, such as smart bracelets and patches, now come equipped with sensors that monitor vital signs, hormone levels, and other physiological metrics related to women’s health. For example, wearables like Ava use physiological data to track fertility windows, offering non-invasive ways for women to manage fertility planning. These devices are becoming more sophisticated, with advancements in biosensing technologies that allow for real-time monitoring of hormone fluctuations, stress levels, and even sleep patterns—factors that directly impact reproductive and overall health. The integration of wearables with smartphone apps also enhances user experience by syncing data for comprehensive health tracking and analysis.

Advances in telemedicine and remote healthcare services are further expanding the FemTech market. Virtual healthcare platforms are making it easier for women to access medical consultations, especially in areas such as prenatal care, sexual health, and menopause management. Telemedicine services that specialize in women’s health offer a convenient way for patients to receive expert advice, prescriptions, and treatment options without needing to visit a clinic in person. This accessibility is particularly valuable for women living in rural or underserved areas, where access to specialized healthcare may be limited. With the rise of telemedicine and AI-powered diagnostics, FemTech is improving the quality of care for women by making it more convenient, personalized, and readily available.

How Are Changing Consumer Preferences and Societal Trends Shaping the FemTech Market?

Changing consumer preferences and societal trends are playing a crucial role in shaping the global FemTech market, particularly as more women demand personalized, convenient, and accessible healthcare solutions. One of the key drivers of this trend is the increasing focus on self-care and preventive health. Women are becoming more proactive about managing their health, seeking tools that enable them to track, understand, and improve their physical and mental well-being. FemTech solutions, such as fertility tracking apps, period management tools, and menopause support devices, align with this trend by offering customized healthcare options that help women manage their unique needs without relying solely on traditional healthcare providers.

The increasing awareness of gender-specific healthcare challenges is also influencing consumer behavior. For decades, women's health issues, such as menstrual disorders, endometriosis, and menopause, were either underdiagnosed or under-researched. This gap in healthcare services has led to a demand for specialized solutions that cater specifically to women's needs. Consumers are seeking products and services that provide real solutions to these issues, from hormone-monitoring wearables to pelvic floor trainers, which have opened up new avenues for FemTech innovation. These trends are also reflected in the demand for products that help manage sexual health, such as smart Kegel trainers or apps that provide sexual health education, all of which contribute to more comprehensive women’s health management.

The societal push for gender equality and representation in all sectors, including healthcare, is another important trend shaping the FemTech market. Women entrepreneurs, innovators, and healthcare professionals are leading the charge in developing products and services that cater to women’s health, ensuring that these needs are prioritized within the broader healthcare system. This has also resulted in more venture capital investment into FemTech startups, as investors recognize the untapped potential and profitability of the market. Additionally, discussions around reproductive rights, gender parity in healthcare, and the destigmatization of women’s health issues have made it easier for FemTech companies to gain visibility and market their products more effectively.

Moreover, the rise of digital platforms and social media has enabled FemTech companies to engage directly with consumers, creating a community-driven approach to healthcare. Many FemTech brands use social media to educate and empower women about their health, addressing topics that have historically been considered taboo, such as menstruation, fertility, and menopause. This open dialogue between companies and consumers is creating a more inclusive environment, where women feel more comfortable discussing their health needs and seeking solutions tailored specifically for them. These changing consumer preferences, coupled with societal trends toward gender equality and transparency, are driving growth in the FemTech market and creating a more personalized healthcare experience for women.

What Is Driving the Growth of the Global FemTech Market?

The growth of the global FemTech market is being driven by several key factors, including increased investment in women’s health solutions, technological innovation, and rising consumer demand for personalized healthcare. One of the primary drivers of this growth is the increasing attention and funding from venture capitalists and healthcare investors who recognize the significant market potential in FemTech. Historically, women’s health has been underfunded and underrepresented in healthcare innovation, but recent years have seen a surge in investment as the industry acknowledges the need for specialized products and services. FemTech startups focusing on reproductive health, maternal care, and menopause management have gained substantial traction, with several companies securing large rounds of funding to develop cutting-edge products and expand their market presence.

Another significant driver of growth is the expanding awareness of women’s health issues and the shift toward preventive care. With the rise of wearable technology and mHealth apps, women are increasingly able to take control of their health by tracking their menstrual cycles, monitoring fertility, and managing chronic conditions in real time. These technologies empower women to make informed healthcare decisions and seek early interventions when needed, reducing the burden on traditional healthcare systems and promoting long-term health outcomes. The demand for preventive health solutions, particularly in areas like fertility management and pregnancy care, is expected to drive further expansion of the FemTech market.

The growing global focus on improving women’s health outcomes is also playing a key role in driving FemTech adoption. Governments and healthcare organizations worldwide are launching initiatives aimed at addressing women’s health challenges, from improving access to reproductive healthcare to providing better maternal care services. This is particularly evident in developing regions where access to healthcare is limited, and FemTech solutions offer an efficient way to bridge the gap in women’s healthcare. Mobile health platforms that provide access to telemedicine, educational resources, and health tracking tools are particularly valuable in these areas, driving market growth and improving health equity.

Lastly, societal trends toward wellness and personalized healthcare are significantly contributing to the growth of the FemTech market. As consumers increasingly prioritize self-care and personalized health solutions, FemTech products are becoming a key component of wellness routines for women of all ages. From fertility tracking devices and apps to hormone-monitoring wearables and pelvic health solutions, FemTech offers products that provide real-time insights and customized care, making it easier for women to manage their health on their own terms. This rising demand for personalized and tech-driven healthcare is encouraging innovation and investment in FemTech, positioning it for continued growth in the global market.

The combination of increased investment, technological advancements, growing consumer demand for preventive and personalized care, and a global focus on improving women’s health outcomes is driving the rapid expansion of the global FemTech market. As the healthcare industry continues to prioritize women's health and address long-standing gaps in care, FemTech is poised to play a pivotal role in transforming the future of healthcare for women worldwide.

Select Competitors (Total 39 Featured) -

  • Aavia
  • Allara Health
  • Athena Feminine Technologies, Inc.
  • BioWink GmbH (Clue)
  • Bloomlife
  • Canopie Inc.
  • Coroflo Limited
  • Flo Health
  • Glow Inc.
  • LunaJoy

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • FemTech - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Womens Health and Wellness Propels Growth in FemTech Market
    • Case Overview: Growth in Digital Health Platforms Fuels Adoption of FemTech Solutions
    • Technological Innovations in Fertility Tracking and Reproductive Health Strengthen Business Case for FemTech
    • Focus on Menstrual Health and Hormonal Wellness Drives Market Adoption of FemTech Apps
    • Increasing Investments in Women-Centric Startups Expands Opportunities for FemTech Innovations
    • Case Overview: Rising Popularity of Telemedicine and Virtual Healthcare Bodes Well for FemTech Market Growth
    • Focus on Maternal and Prenatal Care Strengthens Market Adoption of FemTech Solutions
    • Focus on Sexual Health and Wellness Drives Innovation in FemTech Products and Services
    • Increasing Use of FemTech for Mental Health and Wellbeing Strengthens Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World FemTech Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for FemTech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Consumer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Consumer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Direct-to-Consumer End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Direct-to-Consumer End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Fertility Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Fertility Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for FemTech by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for FemTech by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • FemTech Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for FemTech by Offering - Devices, Software, Consumer Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for FemTech by Offering - Devices, Software, Consumer Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for FemTech by Offering - Percentage Breakdown of Value Sales for Devices, Software, Consumer Products and Services for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for FemTech by End-Use - Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for FemTech by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Direct-to-Consumer End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use, Fertility Clinics End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION